Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic Response-Reference-Cited by-同舟云学术

Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic Response

Published:2017-01-05 Issue:1 Volume:12 Page:e0168713
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Asselah Tarik,Moreno Christophe,Sarrazin Christoph,Gschwantler Michael,Foster Graham R.,Craxí Antonio,Buggisch Peter,Sanai Faisal,Bicer Ceyhun,Lenz Oliver,Van Dooren Gino,Nalpas Catherine,Lonjon-Domanec Isabelle,Schlag Michael,Buti Maria

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference60 articles.

1. European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C. September 2016. Available at: http://www.easl.eu/medias/cpg/HCV2016/English-report.pdf [last accessed 22 November 2016].

2. My treatment approach to chronic hepatitis C virus;ML Shiffman;Mayo Clin Proc,2014

3. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource;DB Smith;Hepatology,2014

4. Is 3 the new 1: perspectives on virology, natural history and treatment for hepatitis C genotype 3;EB Tapper;J Vir Hepat,2013

5. Management of hepatitis C virus genotype 4: recommendations of an international expert panel;MA Khattab;J Hepatol,2011

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C genotype 4: A report on resistance‐associated substitutions inNS3,NS5A,andNS5Bgenes;Reviews in Medical Virology;2020-06

2. Pooled Prevalence of NS5A Resistance-Associated Substitutions in Chronic HCV Genotype 3 Infection: A Study Based on Deposited Sequences in GenBank;Microbial Drug Resistance;2019-09-01

3. Treatment of hepatitis C virus genotype 4 in the DAA era;Virology Journal;2018-11-22

4. Eliminating hepatitis C within low-income countries – The need to cure genotypes 4, 5, 6;Journal of Hepatology;2018-04

5. Efficacy of elbasvir and grazoprevir in participants with hepatitis C virus genotype 4 infection: A pooled analysis;Liver International;2018-03-31